Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.
暂无分享,去创建一个
L. Vassilev | L. Cigliano | S. Theurich | P. Daniel | R. Manz | R. Bargou | K. Bommert | M. Chatterjee | T. Stühmer | C. Gerecke | P. Herrmann | M. Hildebrandt | H. Gollasch